Skip to main content
logo
Radiopharm Theranostics Limited (ASX:RAD)
Australia flag Australia · Delayed Price · Currency is AUD
0.0140
0.00 (0.00%)
Jul 31, 2026, 4:11 PM AEST

Radiopharm Theranostics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
16.2812.511.966.21--
Revenue Growth
30.10%538.86%-68.46%---
Gross Profit
-22.22-18.6-19.65-13.32-7.49-
Operating Income
-41.61-35.13-35.33-28.59-19.93-1.16
Net Income
-46.58-38.34-47.95-34.61-30.42-1.16
Earnings Per Share
-0.02-0.02-0.12-0.11-0.17-
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
34.5229.1218.5811.726.980.03
Total Debt
-----0.06
Net Cash (Debt)
34.5229.1218.5811.726.98-0.03
Net Cash Growth
18.54%56.75%58.77%-56.64%--
Net Cash Per Share
0.010.010.050.040.15-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-37.1-36.65-22.98-23.2-9.91-0.08
Capital Expenditures
----0.05-0-
Free Cash Flow
-37.1-36.65-22.98-23.25-9.91-0.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
-136.51%-148.63%--214.52%--
Operating Margin
-255.63%-280.77%-1803.82%-460.41%--
Pretax Margin
-287.54%-305.62%-2443.31%-556.75%--
Profit Margin
-286.16%-306.44%-2448.23%-557.36%--
FCF Margin
-227.92%-292.88%-1173.12%-374.36%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
3.384.168.935.74--